Pregnancy skincare guide: what is safe, what to avoid, and managing skin changes

Pregnancy skincare generates more contradictory online advice than almost any other topic — some sources ban everything, others claim everything is fine. Here is the evidence-based guide to what is actually known and why.

How to evaluate pregnancy skincare safety

The evidence problem

Randomized controlled trials are not conducted in pregnant populations for ethical reasons — evidence for ingredient safety (or harm) in pregnancy comes from:
Animal teratogenicity studies — high-dose administration; may not reflect typical topical use
Case reports — isolated documented fetal harm from specific products
Pharmacokinetic data — measuring systemic absorption from topical application
Epidemiological data — large population-level associations

The practical implication: "No evidence of harm" is different from "proven safe." Many ingredients have no pregnancy safety data at all — absence of evidence is not evidence of safety. The precautionary principle applies: avoid ingredients with known or plausible risk when safer alternatives exist.

---

Contraindicated ingredients

Retinoids (all forms) — avoid

All topical retinoids are contraindicated in pregnancy, regardless of form:
Tretinoin (retinoic acid)
Retinol
Retinaldehyde (retinal)
Adapalene
Tazarotene
Retinyl palmitate (at high concentrations)
Granactive retinoid (HPR)

Mechanism of concern: Retinoic acid (the active form all retinoids convert to) is a potent teratogen. Oral isotretinoin causes severe birth defects in >25% of pregnancies — the most severe retinoid teratogenicity profile. Topical retinoids are absorbed systemically in small amounts:

Tretinoin cream: systemic absorption 1–2% of applied dose
Retinol: converted to retinoic acid after absorption — absorbed at low but non-zero levels

The case reports: Multiple case reports of fetal retinoic acid embryopathy from prolonged high-dose topical tretinoin exist, though rare. The overall risk from occasional topical use is considered low — but because effective, safer alternatives exist, retinoids are universally avoided during pregnancy.

Postpartum resumption: Retinoids can resume after delivery — no special delay required for formula-feeding mothers; breastfeeding mothers typically hold retinoids as a precaution (systemic absorption can reach breast milk, though levels are very low).

Hydroquinone — avoid

Systemic absorption from topical hydroquinone application is significant (35–45% absorption in some studies). In the absence of established pregnancy safety data and given this absorption, hydroquinone is avoided in pregnancy.

For chloasma (pregnancy melasma): Use azelaic acid 15–20% (Category B, considered safe) or topical niacinamide + tranexamic acid. These address the hyperpigmentation without the hydroquinone absorption concern.

High-dose salicylic acid — caution

OTC 0.5–2% leave-on: The systemic absorption from low-concentration topical salicylic acid is minimal — many dermatologists and OBs consider 2% leave-on acceptable in limited areas during pregnancy.

High-concentration BHA/SA peels (20–30%): Avoid. Systemic salicylate levels from professional peels are meaningful. Salicylates are prostaglandin synthesis inhibitors — in late pregnancy, prostaglandin inhibition can affect fetal renal function and cause premature closure of the ductus arteriosus. The concern is highest in third trimester.

Practical guidance: If using BHA for acne maintenance, 2% leave-on applied to a limited area is generally considered acceptable in first and second trimester; defer to your OB/midwife for guidance specific to your situation.

Benzoyl peroxide — use cautiously

BPO is generally considered Category C (prior classification) — animal studies show effects at high doses; human data is limited but reassuring. Most dermatologists consider topical BPO (2.5–5%) acceptable during pregnancy, particularly for inflammatory acne where the risk of untreated acne (picking, scarring, PIH) may exceed the theoretical BPO risk.

Precautionary approach: Minimize total BPO application area; prefer 2.5% over 10%; avoid application to the breast area during breastfeeding.

---

Safe ingredients during pregnancy

| Ingredient | Safety Evidence | Primary Use |
|---|---|---|
| Azelaic acid 15–20% | Category B; well-studied | Acne, rosacea, chloasma |
| Glycolic acid ≤10% | Considered safe; minimal systemic absorption | Exfoliation, texture |
| Lactic acid ≤10% | Considered safe | Gentle exfoliation, hydration |
| Niacinamide (any %) | Considered safe | Brightening, barrier, sebum |
| Vitamin C (all forms) | Considered safe | Antioxidant, brightening |
| Hyaluronic acid | Considered safe | Hydration |
| Zinc oxide SPF | Preferred; no systemic absorption | UV protection |
| Titanium dioxide SPF | Considered safe | UV protection |
| Ceramides | Considered safe | Barrier repair |
| Glycerin | Considered safe | Humectant |
| Tranexamic acid (topical 2–5%) | Limited data but no known concern | Brightening (chloasma) |
| Colloidal oatmeal | Considered safe | Soothing, sensitive skin |
| Centella asiatica | Considered safe | Calming, barrier support |
| Peptides | Considered safe (topical, not injected) | Anti-aging maintenance |

---

Managing pregnancy-specific skin changes

Chloasma (melasma of pregnancy)

Appears in 50–75% of pregnancies — the cheeks, forehead, and upper lip develop symmetrical hyperpigmented patches from estrogen and progesterone stimulating melanocytes. Often worsens with UV exposure.

Management during pregnancy:
Mandatory: SPF 50+ (tinted, with iron oxides for visible light protection) — every morning, reapply outdoors
First-line: Azelaic acid 15–20% — proven safe in pregnancy, effective for melasma
Adjunct: Niacinamide 5% + tranexamic acid 2–3% — complementary mechanisms, considered safe
Avoid: Hydroquinone (absorption concern), laser (hormonal trigger persists — high relapse risk)

Many cases of pregnancy melasma improve significantly in the months after delivery as estrogen levels normalize. Some persist — particularly in women with continued UV exposure without adequate protection.

Pregnancy acne

Hormonal shifts (particularly progesterone's pro-sebaceous effect) cause acne flares in ~50% of pregnancies, often in the first trimester.

Safe first-line:
Gentle cleanser twice daily
Azelaic acid 15–20% (treats both acne and any resulting hyperpigmentation)
BPO 2.5% applied to specific areas (not widespread)
Niacinamide 5% for sebum regulation and anti-inflammatory effect

Refer to OB/midwife: For decisions about oral antibiotics (erythromycin is considered safest; doxycycline avoided after first trimester), which require prescriber involvement.

Stretch marks (striae gravidarum)

No topical ingredient has robust RCT evidence for preventing stretch mark formation — they are primarily a function of skin elasticity genetics and rapid volume expansion rate. Centella asiatica extract (TECA) has the most evidence among topical agents for reducing striae severity, based on two small RCTs.

Keeping skin well-moisturized (any safe emollient) reduces the tightness and itching that accompanies stretch mark formation and may marginally reduce severity — the evidence for prevention remains weak.

---

Postpartum routine rebuild

After delivery and once breastfeeding is established or ended, most ingredients can be reintroduced:
Immediately post-delivery: Retinoids remain deferred during breastfeeding (precautionary; systemic levels in milk are very low)
After breastfeeding ends: Full routine reintroduction; tretinoin, adapalene, AHAs, and hydroquinone all appropriate
Ongoing chloasma: Continue SPF discipline + azelaic acid; add tretinoin and HQ once breastfeeding complete for more aggressive treatment

---

Looking for a pregnancy skincare or postpartum consultation? Browse med spa providers on MedSpot →